Page 79 of Pharma and Healthcare

Mystery fever, Mystery fever in Mumbai, dengue-like symptoms, healthcare news,

Mumbai reports mystery disease! Patients complain of dengue-like symptoms – here’s what doctor says

Mystery fever in Mumbai: The patients are showing symptoms like an unusual fever that lasts for 4-5 days, rashes, heaviness…

October 31, 2023 16:31 IST

Antibiotics, childhood infections, antibiotic resistance, healthcare news,

Common antibiotics for childhood infections are not effective anymore; Read to know more

According to the researchers, the inability to prevent infections could also seriously compromise surgery and procedures such as chemotherapy.

October 31, 2023 16:01 IST

Price revision, Drug price, NPPA, drug formulations, NPPA news, healthcare news,

NPPA revises prices of 438 drug formulations over calculation anomaly

It is noteworthy that the Authority has revised the ceiling prices of scheduled formulations based on the WPI for the…

October 31, 2023 11:33 IST

Innovent, Innovent drug, healthcare news, pharma news,

Innovent drug continues to take weight off in 48 week trial

Mazdutide targets two different receptors in the body — GLP-1R and GCGR — to increase both energy expenditure and metabolic…

October 31, 2023 10:00 IST

GlobalData, Lebrikizumab, dermatitis, healthcare news, pharma news,

FDA rejection to delay Lebrikizumab chances to enter atopic dermatitis market, says GlobalData

According to GlobalData’s report on AD, the market for this indication is anticipated to reach $17.4 billion in 2030 across…

October 31, 2023 09:00 IST

healthcare, research and development, diseases, healthcare news,

Research and innovation in the pharmaceutical sector

The Policy is intended to incentivize investment specifically in production of biopharmaceuticals, patented drugs, new technology in medical devices for…

October 31, 2023 07:00 IST

ICMR, ICMR COVID-19, COVID, COVID-19, Indian Council of Medical Research

Covid vaccination didn’t increase risk of sudden deaths among young adults in India: Study

Factors that did increase such chances included being in the hospital for Covid in the past and certain behaviours like…

October 30, 2023 20:40 IST

GSK, cancer drug Jemperli, chemotherapy, endometrial cancer, gynaecologic cancer, latest healthcare news, latest news,

GSK says endometrial cancer drug meets overall survival goal in late-stage trial

British drugmaker GSK said on Monday its cancer drug Jemperli, when combined with chemotherapy.

October 30, 2023 18:23 IST

Health Insurance, Health Insurance claim, healthcare news, financial transactions,

By Dec-end, India set to showcase a workable insurance claims exchange

The National Health Claims Exchange is a digital deliverance of sorts that could sharply cut down both the time spent…

October 30, 2023 16:38 IST

Molbio Diagnostics, breast cancer screening, diagnostics news, healthcare news,

Molbio Diagnostics forays into breast cancer screening through a partnership with Niramai Health Analytix

Through this collaboration, Molbio will promote and distribute Thermalytix in both public and private healthcare markets globally.

October 30, 2023 15:02 IST

Divi's Laboratories, Pharmaceutical, pharma industry, Q2FY24 results, profit, revenue, EBITDA

Sun Pharma and Zydus sign licensing agreement to co-market critical drug for Chronic Kidney Disease patients in India

Under the terms of this agreement, Zydus has granted Sun Pharma semi-exclusive rights to co-market the product in India.

October 30, 2023 13:23 IST

Blackstone, CARE Hospital, TPG, private equity, healthcare news,

Blackstone acquires CARE Hospitals and KIMSHEALTH

The combined platform will deliver advanced comprehensive care in more than 30 clinical specialties, including cardiac sciences, oncology, neurosciences, renal…

October 30, 2023 12:58 IST

Novartis, Kidney disease, nephropathy, healthcare news, pharma news,

Novartis’ investigational drug to treat kidney disease demonstrates promising results in Phase III study

The addition of these two late-stage medicines, as well as an early-stage pipeline, expands the Novartis renal portfolio.

October 30, 2023 12:16 IST

Novo Nordisk, GLP1, pharma sales, healthcare news, pharma news,

Novo Nordisk’s injectable GLP-1RA sales may increase upon imminent label expansion, says GlobalData

The FLOW trial compared the effect of Ozempic 1.0mg to placebo as an add-on to the standard of care treatment…

October 30, 2023 07:00 IST

Dr Reddy’s Laboratories, Q2FY24 results, pharmaceutical, revenue, profit, EBITDA, capital expenditure, R&D investments, cash flow, Generics business, new products, Pharmaceutical Services and Active ingredients, price erosion

Dr. Reddy’s Q2 FY24 Results: Pharma major to focus on acquisitions, bringing more generic and innovative products in oncology to India market

In terms of our expectations for the Indian market, India market continues to be the focus market, M. V. Ramana,…

October 28, 2023 11:17 IST

Nipah, Nipah news, Nipah virus, Nipah outbreak, Nipah in Kerala, ICMR, kerala news, Kerala latest news

After Kozhikode outbreak, ICMR detects presence of Nipah virus in bats of Kerala’s Wayanad

The minister also said that due to its robust health ecosystem, Kerala has managed to keep the mortality rate of…

Updated: October 26, 2023 16:33 IST

Strides Pharma, Strides Pharma Q3 results, quarter earnings, profit, revenue, EBITDA, pharmaceutical, US Business

Zydus Lifesciences begins Phase II trial of novel drug to treat fatal motor neuron disease

ALS patients experience neuroinflammation and rapid neurodegeneration leading to a steady loss of the ability to move, speak, eat and…

October 26, 2023 09:00 IST

CDSCO, cancer drug, immunotherapy, healthcare news, pharma news,

DCGI approves MSD India’s drug to treat triple-negative breast cancer and renal cell carcinoma

Triple-negative breast cancer (TNBC) is the most aggressive type of breast cancer, which has the highest risk of recurrence within…

October 26, 2023 08:00 IST

Related News

According to Legg, the disruption will be uneven across industries.

AI will end work-from-home, says Google DeepMind Co-Founder Shane Legg

Indian Govt urges vehicle owners, DL holders to update mobile number on Vahan, Sarathi portals: Here’s how

Delhi makes two key GRAP-4 rules permanent to combat ‘severe’ pollution – All you need to know

Hidden Gems: The electrification play inside this company’s portfolio.

The ‘Birla’ lineage small-cap quietly powering India’s electronics boom

Meet Kalyani Ramadurgam: Indian-origin techie who helped Apple fight terrorism, now a startup founder, makes Forbes 30 Under 30 2026

Meet Kalyani Ramadurgam: Indian-origin techie who helped Apple fight terrorism, makes Forbes 30 Under 30

Markets see profit booking: Nifty breaches 26,000, Sensex falls 350 points

Market55 min ago

Indian equity benchmarks closed lower on the last week of the year, with Nifty 50 and BSE Sensex falling 0.38% and 0.41%. Nifty Bank, mid- and small-cap stocks also closed lower. Experts believe profit booking and weak technical indicators caused the decline, with a potential consolidation phase ahead. Top gainers were Tata Steel, Tata Consumer Products, and Asian Paints.

View all shorts